Justin Chakma - Chief Business Officer at ARS Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
SPRY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Justin Chakma - trading volume in the past year for ARS Pharmaceuticals, Inc.

Holdings reported by Justin Chakma for ARS Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 136K $1.65M $12.06 Dec 13, 2024 Direct
Stock Option (Right to Buy) 55.5K Dec 13, 2024 Direct Common Stock

Transactions reported by Justin Chakma for ARS Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.